Oral transmucosal fentanyl citrate as breakthrough pain relieving medication: A pilot study
ABSTRACT Background: Breakthrough pain in cancer patients is a common and distressing symptom that significantly impacts their quality of life. Traditional pain management strategies often fail to provide adequate relief. Oral transmucosal fentanyl citrate (OTFC) has emerged as a rapid-onset opioid...
Saved in:
Published in | Current medicine research and practice Vol. 14; no. 4; pp. 145 - 149 |
---|---|
Main Authors | , , , , , |
Format | Journal Article |
Language | English |
Published |
Medknow Publications and Media Pvt. Ltd
01.07.2024
Wolters Kluwer Medknow Publications |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Be the first to leave a comment!